enGene Holdings Inc. Announces Corporate Name Change to enGene Therapeutics Inc.

On April 7, 2026, enGene Therapeutics Inc. (formerly enGene Holdings Inc.) announced a formal corporate name change from 'enGene Holdings Inc.' to 'enGene Therapeutics Inc.' The name change became effective on April 8, 2026, following the filing of a notice of alteration with the Province of British Columbia Registrar of Companies on April 6, 2026. The company's Board of Directors amended the Articles of Incorporation to reflect the new name. Despite the corporate rebranding, the company’s common shares and warrants will continue to trade on the Nasdaq Stock Market under the existing ticker symbols 'ENGN' and 'ENGNW,' respectively. The filing clarifies that no other substantive changes were made to the company's Articles or capital structure. The name change was authorized by a directors' resolution adopted on March 24, 2026. The company remains incorporated under the Business Corporations Act of British Columbia.